TRAPPC11

protein-coding

trafficking protein particle complex subunit 11, the group of Trafficking protein particle complex subunits

Gene summary

The protein encoded by this gene is a subunit of the TRAPP (transport protein particle) tethering complex, which functions in intracellular vesicle trafficking. This subunit is involved in early stage endoplasmic reticulum-to-Golgi vesicle transport. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2013]

Previous symbols:
  • C4orf41

MANE transcript

NM_021942.6

Inheritance

AR

ClinVar variants

P:76U:443B:260

Top phenotype

Muscular dystrophy, limb-girdle, autosomal recessive, 18

gnomAD constraint

pLI —, LoF o/e 0.41

Max pathogenic AF

—

Genomic locus

chr4:183,659,267-183,713,594

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~54.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

autosomal recessive limb-girdle muscular dystrophy type R18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: PanelApp Australia

autosomal recessive limb-girdle muscular dystrophy type R18DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: Myriad Women's Health

autosomal recessive limb-girdle muscular dystrophy type R18DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: G2P

autosomal recessive limb-girdle muscular dystrophy type R18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: Labcorp Genetics (formerly Invitae)

autosomal recessive limb-girdle muscular dystrophy type R18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: Laboratory for Molecular Medicine

This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.

autosomal recessive limb-girdle muscular dystrophyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0015152

Submitter: ClinGen

*TRAPPC11* was first reported in relation to autosomal recessive limb-girdle muscular dystrophy (LGMDR18 included) in 2013 (Bögershausen et al., PMID: 23830518). Autosomal recessive limb-girdle muscular dystrophy is typically characterized by childhood-onset of proximal muscle weakness resulting in gait abnormalities and scapular winging. Many patients have elevated serum creatine kinase. A subset of patients displayed hyperkinetic movement disorder with chorea, ataxia, or dystonia and global developmental delay. Additional phenotypes such as alacrima, achalasia, cataracts, or hepatic steatosis have been observed in the literature. *TRAPC11* has been noted to be associated with autosomal recessive limb-girdle muscular dystrophy, although many authors have noted a phenotypic expansion in the literature, where the term *TRAPPC11*-related myopathy has been coined. ORPHANET lists intellectual disability-hyperkinetic movement-truncal ataxia syndrome (ORPHA:369847) and Triple A syndrome (ORPHA:869) as additional gene-disease assertions. For the purposes of this curation, cases have been scored under the autosomal recessive limb-girdle muscular dystrophy (LGMDR18 included) disease entity, which falls under the umbrella term of *TRAPPC11*-related myopathies in MONDO. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Summary of Case Level Data: 12 POINTS. Variants in this gene have been reported in at least 14 probands in 9 publications (PMIDs: 23830518, 26322222, 27707803, 28827486, 31575891, 30105108, 29855340, 27862579, 34648194). Variants in this gene segregated with disease in 7 additional family members in 2 families (PMID:23830518). Not all probands were scored due to the absence of in trans confirmation of compound heterozygous variants, however, the maximum score for genetic evidence of 12 points has been reached. The majority of pathogenic variants in *TRAPPC11* reported in ClinVar are nonsense or frameshift variants where loss of function is the mechanism of disease. Summary of Experimental Data: 2.5 POINTS. This gene-disease association is also supported by animal model and functional alteration in human cell line (PMID: 26912795, 21525244). Loss-of-function mutations in the zebrafish ortholog of C11 have been found in the foie gras mutant, characterized by steatohepatitis and eye development defects (PMID:26912795). Mutant *TRAPPC11* zebrafish exhibits a phenotype similar to that observed in humans with respect to Golgi complex formation and endoplasmic reticulum organization supporting the role of *TRAPPC11* in the characteristic muscle phenotypes. Research conducted using HeLa cell lines revealed the role of *TRAPPC11* subunit it protein glycosylation. In HeLa cells siRNA knockdown of C11 leads to impaired binding of other TRAPP components, functional impairment of the complex, retention of secretory proteins in the ERGIC, and fragmentation of the Golgi apparatus (PMID:21525244). In summary, there is definitive evidence to support this gene-disease relationship. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Limb-Girdle Muscular Dystrophy GCEP on the meeting date of December 14th, 2021 (SOP Version 8).

triple-A syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009279

Submitter: Orphanet

intellectual disability-hyperkinetic movement-truncal ataxia syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0018243

Submitter: Orphanet

autosomal recessive limb-girdle muscular dystrophy type R18SUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014144

Submitter: Orphanet

Clinical Genomic Database (CGD)

Muscular dystrophy, limb-girdle, autosomal recessive, 18AR

Manifestation: Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 23830518; 27707803; 28827486Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to TRAPPC11 variants in ClinVar

11 Conditions Cataloged
Autosomal recessive limb-girdle muscular dystrophy type R18Total: 863
not providedTotal: 219
Inborn genetic diseasesTotal: 127
not specifiedTotal: 65
TRAPPC11-related disorderTotal: 19
Autosomal recessive limb-girdle muscular dystrophyTotal: 5
Limb-girdle muscular dystrophyTotal: 2
Muscular dystrophy, limb-girdle, autosomal recessive 23Total: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_021942.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
12
clinvar
238
clinvar
1
clinvar
251
missense
5
clinvar
424
clinvar
19
clinvar
2
clinvar
450
nonsense
12
clinvar
11
clinvar
3
clinvar
26
start loss
1
clinvar
1
frameshift
18
clinvar
14
clinvar
32
splice donor/acceptor (+/-2bp)
1
clinvar
15
clinvar
3
clinvar
19
Total31454432573779

Highest pathogenic variant AF is 0.00006485206

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 39 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_021942.6RefSeqNP_068761.429MANE Select
ENST00000334690.11EnsemblENSP00000335371.629MANE Select
NM_199053.3RefSeqNP_951008.130Standard
ENST00000357207.8EnsemblENSP00000349738.430Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
trappc11Danio rerio

Structure: hepatocyte

Quality: increased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Vesicle-mediated transport
  • Membrane Trafficking
  • Rab regulation of trafficking
  • RAB GEFs exchange GTP for GDP on RABs

Biological Process

  • endoplasmic reticulum to Golgi vesicle-mediated transport
  • Golgi organization
  • protein complex oligomerization
  • regulation of protein complex stability

Molecular Function

  • protein binding
  • Rab guanyl-nucleotide exchange factor activity

Cellular Component

  • Golgi apparatus
  • cytosol
  • TRAPP complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000334690
Coding exons
29
Length
54326
Individuals with no LoFs
125670
Homozygous LoFs
0
Heterozygous LoFs
78
Defined
125748
p
0.000310
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.9325345980.8930.00003007426
Missense (PolyPhen)6892.0140.739021085
Synonymous0.5332092190.9540.00001192132
Loss of Function4.462867.50.4150.00000349814

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000360.00035rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000340.00033rare
Finnish0.0000920.000092rare
European (Non-Finnish)0.000390.00039rare
South Asian0.000310.00029rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage. {ECO:0000269|PubMed:21525244, ECO:0000269|PubMed:27862579}.;
Disease
DISEASE: Limb-girdle muscular dystrophy 2S (LGMD2S) [MIM:615356]: A form of limb-girdle muscular dystrophy characterized by proximal muscle weakness with childhood onset, resulting in gait abnormalities and scapular winging. Serum creatine kinase is increased. A subset of patients may show a hyperkinetic movement disorder with chorea, ataxia, or dystonia and global developmental delay. {ECO:0000269|PubMed:23830518}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.106

Intolerance Scores

RVIS EVS
-0.97
RVIS percentile EVS
8.99

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
N
Indispensability score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.